Archive - 2012

17 December 2012 - Press Releases

Collaboration with Babraham Institute to explore PI3 kinase inhibitors in the treatment of inflammatory diseases

Karus Therapeutics Announces Collaboration with Babraham Institute to Explore PI3 Kinase Inhibitors in the Treatment of Inflammatory Diseases

Read more

06 September 2012 - Press Releases

Karus Therapeutics secures Series B financing from a syndicate of leading VC investors

Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, announces the closing of its Series B investment, which includes a first tranche of $7.6 million.

Read more